ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
12 01 2021
Historique:
received: 03 09 2020
accepted: 27 10 2020
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 15 5 2021
Statut: ppublish

Résumé

von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients. These evidence-based guidelines from the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF), and the World Federation of Hemophilia (WFH) are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD. ASH, ISTH, NHF, and WFH formed a multidisciplinary guideline panel. Three patient representatives were included. The panel was balanced to minimize potential bias from conflicts of interest. The University of Kansas Outcomes and Implementation Research Unit and the McMaster Grading of Recommendations Assessment, Development and Evaluation (GRADE) Centre supported the guideline development process, including performing and updating systematic evidence reviews (through November 2019). The panel prioritized clinical questions and outcomes according to their importance to clinicians and patients. The panel used the GRADE approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment. The panel agreed on 12 recommendations and outlined future research priorities. These guidelines make key recommendations regarding prophylaxis for frequent recurrent bleeding, desmopressin trials to determine therapy, use of antiplatelet agents and anticoagulant therapy, target VWF and factor VIII activity levels for major surgery, strategies to reduce bleeding during minor surgery or invasive procedures, management options for heavy menstrual bleeding, management of VWD in the context of neuraxial anesthesia during labor and delivery, and management in the postpartum setting.

Sections du résumé

BACKGROUND
von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients.
OBJECTIVE
These evidence-based guidelines from the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF), and the World Federation of Hemophilia (WFH) are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD.
METHODS
ASH, ISTH, NHF, and WFH formed a multidisciplinary guideline panel. Three patient representatives were included. The panel was balanced to minimize potential bias from conflicts of interest. The University of Kansas Outcomes and Implementation Research Unit and the McMaster Grading of Recommendations Assessment, Development and Evaluation (GRADE) Centre supported the guideline development process, including performing and updating systematic evidence reviews (through November 2019). The panel prioritized clinical questions and outcomes according to their importance to clinicians and patients. The panel used the GRADE approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.
RESULTS
The panel agreed on 12 recommendations and outlined future research priorities.
CONCLUSIONS
These guidelines make key recommendations regarding prophylaxis for frequent recurrent bleeding, desmopressin trials to determine therapy, use of antiplatelet agents and anticoagulant therapy, target VWF and factor VIII activity levels for major surgery, strategies to reduce bleeding during minor surgery or invasive procedures, management options for heavy menstrual bleeding, management of VWD in the context of neuraxial anesthesia during labor and delivery, and management in the postpartum setting.

Identifiants

pubmed: 33570647
pii: S2473-9529(21)00028-8
doi: 10.1182/bloodadvances.2020003264
pmc: PMC7805326
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-325

Informations de copyright

© 2021 by The American Society of Hematology.

Références

Breastfeed Med. 2014 Oct;9(8):407-10
pubmed: 25025926
Haemophilia. 2020 Jan;26(1):106-116
pubmed: 31769905
Thromb Res. 2007;120(3):387-90
pubmed: 17056101
Haemophilia. 2020 Mar;26(2):e34-e37
pubmed: 31846115
Haemophilia. 2011 Nov;17(6):895-905
pubmed: 21535320
Blood Transfus. 2019 Sep;17(5):391-398
pubmed: 30747707
Thromb Haemost. 2011 Nov;106(5):885-92
pubmed: 21947221
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
Obstet Gynecol Surv. 1998 Jul;53(7):450-5
pubmed: 9662731
J Thromb Haemost. 2006 Oct;4(10):2103-14
pubmed: 16889557
J Pediatr Hematol Oncol. 2005 Jul;27(7):357-63
pubmed: 16012324
Am J Respir Crit Care Med. 2009 Sep 15;180(6):564-80
pubmed: 19734351
J Thromb Haemost. 2015 Sep;13(9):1585-9
pubmed: 25930155
Haemophilia. 2008 Jan;14(1):56-64
pubmed: 17941828
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
J Clin Epidemiol. 2014 Nov;67(11):1222-8
pubmed: 24970099
Pol Arch Intern Med. 2018 Aug 31;128(7-8):488-490
pubmed: 30057379
BMC Health Serv Res. 2004 Dec 22;4(1):38
pubmed: 15615589
Blood Coagul Fibrinolysis. 2015 Jun;26(4):383-8
pubmed: 25688461
J Thromb Haemost. 2020 Sep;18(9):2145-2154
pubmed: 32379400
Haemophilia. 2001 May;7(3):258-66
pubmed: 11380629
Cochrane Database Syst Rev. 2019 Feb 13;2:CD009824
pubmed: 30758840
Haemophilia. 2013 Jul;19(4):583-9
pubmed: 23560720
Haemophilia. 2015 Jan;21(1):81-7
pubmed: 25333737
Haemophilia. 2016 Nov;22(6):934-942
pubmed: 27385645
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
CMAJ. 2003 Sep 30;169(7):677-80
pubmed: 14517128
PLoS One. 2016 Oct 25;11(10):e0164683
pubmed: 27780267
Haemophilia. 2017 Mar;23(2):264-272
pubmed: 28026130
Mediterr J Hematol Infect Dis. 2013;5(1):e2013004
pubmed: 23350017
Haemophilia. 2011 Jul;17 Suppl 1:6-13
pubmed: 21692922
Br Med J. 1972 May 6;2(5809):311-3
pubmed: 4553818
J Thromb Haemost. 2020 Aug;18(8):1855-1858
pubmed: 32279414
Haematologica. 2020 Aug;105(8):2032-2037
pubmed: 32554559
Blood Adv. 2018 Jul 24;2(14):1784-1791
pubmed: 30042144
Thromb Haemost. 2010 Nov;104(5):984-9
pubmed: 20886181
Transfusion. 2014 Jul;54(7):1756-68
pubmed: 24617726
J Thromb Haemost. 2013 May;11(5):845-54
pubmed: 23506463
Haemophilia. 2016 Jan;22(1):39-45
pubmed: 26036844
Haemophilia. 2008 Mar;14(2):171-232
pubmed: 18315614
Haemophilia. 2010 Mar;16(2):272-6
pubmed: 19845777
Br J Obstet Gynaecol. 1998 Mar;105(3):314-21
pubmed: 9532993
J Thromb Haemost. 2007 Jun;5(6):1115-24
pubmed: 17403090
Haemophilia. 2015 May;21(3):338-342
pubmed: 25381842
Ann Intern Med. 2015 Oct 6;163(7):548-53
pubmed: 26436619
Br J Haematol. 1971 May;20(5):463-75
pubmed: 4931484
Blood. 2009 Jan 15;113(3):526-34
pubmed: 18805962
Haemophilia. 2000 Mar;6(2):71-7
pubmed: 10781191
Arch Otolaryngol Head Neck Surg. 2002 Dec;128(12):1365-8
pubmed: 12479721
Haemophilia. 2013 Jan;19(1):82-8
pubmed: 22957493
J Pediatr Hematol Oncol. 2014 Aug;36(6):e371-5
pubmed: 24942016
Blood Transfus. 2008 Sep;6 Suppl 2:s26-32
pubmed: 19105507
J Thromb Haemost. 2010 Jan;8(1):213-6
pubmed: 19874468
BJOG. 2004 Dec;111(12):1425-8
pubmed: 15663130
Br J Haematol. 2009 Apr;145(2):212-20
pubmed: 19236375
Haemophilia. 2016 Sep;22(5):e423-6
pubmed: 27478149
Anaesth Intensive Care. 2000 Apr;28(2):199-201
pubmed: 10788975
Drugs. 1985 Mar;29(3):236-61
pubmed: 2580684
Thromb Haemost. 2018 Oct;118(10):1690-1700
pubmed: 30273954
Blood. 1997 Oct 1;90(7):2515-21
pubmed: 9326215
Semin Thromb Hemost. 2016 Feb;42(1):36-41
pubmed: 26595151
J Clin Invest. 1977 Aug;60(2):390-404
pubmed: 17621
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):247-50
pubmed: 11925531
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
Haemophilia. 2008 Jul;14(4):763-7
pubmed: 18445014
Thromb Haemost. 2009 Jun;101(6):1104-11
pubmed: 19492155
Am J Hematol. 2001 Apr;66(4):280-4
pubmed: 11279640
J Pediatr. 2009 Jul;155(1):68-72
pubmed: 19394040
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):596-600
pubmed: 31808831
Haemophilia. 2019 Jan;25(1):101-108
pubmed: 30427095
Haemostasis. 1994 Sep-Oct;24(5):298-303
pubmed: 7843641
Haemophilia. 2012 Sep;18(5):e364-5
pubmed: 22757775
Haemophilia. 2007 Dec;13 Suppl 5:15-24
pubmed: 18078393
Blood. 2008 Apr 1;111(7):3531-9
pubmed: 18230755
Ann Intern Med. 2010 Jun 1;152(11):738-41
pubmed: 20479011
Haemophilia. 2018 May;24(3):460-470
pubmed: 29573506
Haemophilia. 2011 Sep;17(5):752-8
pubmed: 21689209
Haemophilia. 2010 Jan;16(1):101-10
pubmed: 19811543
Minerva Stomatol. 1995 May;44(5):235-40
pubmed: 7476776
Blood. 2020 Sep 3;136(10):1125-1133
pubmed: 32584960
J Clin Epidemiol. 2016 Aug;76:89-98
pubmed: 26931285
Br J Obstet Gynaecol. 1997 Jul;104(7):803-10
pubmed: 9236645
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Br J Haematol. 2014 Nov;167(4):453-65
pubmed: 25113304
Semin Thromb Hemost. 2011 Jul;37(5):560-7
pubmed: 22102200
Contraception. 2011 Mar;83(3):242-7
pubmed: 21310286
Am J Hematol. 2005 Feb;78(2):85-93
pubmed: 15682411
Haemophilia. 2009 Jan;15(1):372-3
pubmed: 19149861
Haemophilia. 2018 Jul;24(4):628-633
pubmed: 29626372
Haemophilia. 2002 Nov;8(6):761-7
pubmed: 12410644
Thromb Haemost. 2002 Feb;87(2):224-30
pubmed: 11858481
Blood Coagul Fibrinolysis. 2016 Oct;27(7):812-816
pubmed: 26761584
Haemophilia. 2011 Jan;17(1):e185-8
pubmed: 20557354
Haemophilia. 2013 Nov;19(6):933-8
pubmed: 23711358
Thromb Haemost. 2011 Jun;105(6):1072-9
pubmed: 21437358
Br Med J. 1972 May 6;2(5809):314-5
pubmed: 4537105
Haemophilia. 2009 Jan;15(1):122-30
pubmed: 19149848
J Clin Epidemiol. 2016 Dec;80:3-7
pubmed: 27452192
Haemophilia. 2008 Mar;14(2):271-5
pubmed: 18194310
Blood Adv. 2021 Jan 12;5(1):280-300
pubmed: 33570651
Haemophilia. 2016 Nov;22(6):906-911
pubmed: 27704714
Heliyon. 2020 Feb 25;6(2):e03426
pubmed: 32140581
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7880-4
pubmed: 1518808
Haemophilia. 2012 Jan;18(1):25-33
pubmed: 21624012
Haemophilia. 2013 Jan;19(1):76-81
pubmed: 22823000
Am J Gastroenterol. 2000 Sep;95(9):2374-6
pubmed: 11007246
Laryngoscope. 2011 Jul;121(7):1399-403
pubmed: 21647890
Haematologica. 2018 Mar;103(3):550-557
pubmed: 29305412
Haemophilia. 2019 May;25(3):e199-e203
pubmed: 30994216
Haemophilia. 2015 Jan;21(1):e44-50
pubmed: 25112927
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S23-6
pubmed: 15849523
Haemophilia. 2010 Jul 1;16(4):615-24
pubmed: 20331755
Haemophilia. 2013 Nov;19(6):887-92
pubmed: 23919249
Fertil Steril. 2008 Sep;90(3):673-7
pubmed: 18001734
J Pediatr Adolesc Gynecol. 2017 Aug;30(4):479-483
pubmed: 27108228
N Engl J Med. 2016 Nov 24;375(21):2067-2080
pubmed: 27959741
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
N Engl J Med. 1980 May 8;302(19):1047-51
pubmed: 6767976
Haematologica. 2007 Jul;92(7):944-51
pubmed: 17606445

Auteurs

Nathan T Connell (NT)

Hematology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Veronica H Flood (VH)

Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI.

Romina Brignardello-Petersen (R)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Rezan Abdul-Kadir (R)

Department of Obstetrics and Gynaecology and Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Foundation Hospital and Institute for Women's Health, University College London, London, United Kingdom.

Alice Arapshian (A)

Middle Village, NY.

Susie Couper (S)

Maylands, WA, Australia.

Jean M Grow (JM)

Department of Strategic Communication, Marquette University, Milwaukee, WI.

Peter Kouides (P)

Mary M. Gooley Hemophilia Treatment Center, University of Rochester, Rochester, NY.

Michael Laffan (M)

Centre for Haematology, Imperial College London, London, United Kingdom.

Michelle Lavin (M)

Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland and National Coagulation Centre, St James's Hospital, Dublin, Ireland.

Frank W G Leebeek (FWG)

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Sarah H O'Brien (SH)

Division of Hematology/Oncology, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH.

Margareth C Ozelo (MC)

Hemocentro UNICAMP, University of Campinas, Campinas, Brazil.

Alberto Tosetto (A)

Hemophilia and Thrombosis Center, Hematology Department, S. Bortolo Hospital, Vicenza, Italy.

Angela C Weyand (AC)

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI.

Paula D James (PD)

Department of Medicine, Queen's University, Kingston, ON, Canada; and.

Mohamad A Kalot (MA)

Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.

Nedaa Husainat (N)

Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.

Reem A Mustafa (RA)

Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH